PixarBio Corporation Builds Commercialization Team Adding Regulatory Affairs, cGMP Manufacturing, Sales/Bus Dev, And Medical Affairs

CAMBRIDGE, Mass--(BUSINESS WIRE)--PixarBio Corporation today announced expansion of the leadership team, to maintain momentum toward multiple FDA approvals of non-opiate and non-addictive pain treatments in 2017.

Dr. Amer Khalil, PixarBio scientific advisory board member has accepted the role of Medical Director. Dr. Khalil, a Harvard trained Neurosurgeon is a long-time collaborator with PixarBio cofounder Frank Reynolds having worked for Mr. Reynolds at InVivo Therapeutics.

Help employers find you! Check out all the jobs and post your resume.

Back to news